Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02790242 · ClinicalTrials.gov registry record
Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy
A clinical trial, sponsored by Columbia University.
- Terminated
- Registry status
- 1,089
- Enrollment target
NCT02790242 is a clinical trial that was terminated before completion, run by Columbia University. The registered enrollment target is 1,089 participants.
The verdict
NCT02790242 was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- 1,089 participants
- Enrollment target
Study Summary
The purpose of this study is to gather information on patients who have heart failure and are eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular assist device (VAD) or 2) heart transplant. the study seeks to determine which patient populations benefit from heart transplant or ventricular assist device. This will allow to offer the state-of-the-art care to the patients in heart failure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,089 participants |
| Start Date | 2013-11 |
| Est. Completion | 2020-02-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02790242
The ClinicalTrials.gov registry entry for NCT02790242 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1,089 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02790242 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02790242 about?
NCT02790242 is a clinical study titled "Registry for Cardiogenic Shock: Utility and Efficacy of Device Therapy". The purpose of this study is to gather information on patients who have heart failure and are eligible for one of the following two procedures: 1) mechanical support, i.e. ventricular assist device (VAD) or 2) heart transplant. the study seeks to determine which patient populations benefit from hear...
What is the current status of trial NCT02790242?
This trial is currently terminated. The enrollment target is 1,089 participants. The study started on 2013-11. Estimated completion is 2020-02-11.
Who is sponsoring clinical trial NCT02790242?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.